ILLUMINA, INC. for ILLUMINA, INC.

Health Issues HCR

H.R. 4128/S. 2209: Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021; all provisions H.R. 6000: Cures 2.0 Act; discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding and National Institutes of Health funding H.R.7667: Food and Drug Amendments of 2022; discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement H.R. 8295/S. 4659: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023; discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding and National Institutes of Health funding S. 2022: Ending the Diagnostic Odyssey Act of 2021; all provisions S. 3799: Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics (PREVENT Pandemics) Act; all provisions S. 4348: Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding and National Institutes of Health funding Public Law No: 117-180: Making continuing appropriations for fiscal year 2023, and for other purposes (H.R. 6833); discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding and National Institutes of Health funding Public Law No: 117-328 (H.R. 2617): Consolidated Appropriations Act, 2023; discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding and National Institutes of Health funding

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2209 (117th), S. 4659 (117th), H.R. 7667 (117th), S. 2022 (117th), H.R. 6833 (117th), S. 3799 (117th), H.R. 4128 (117th), H.R. 6000 (117th), H.R. 2617 (117th), S. 4348 (117th), H.R. 8295 (117th)

Government Issues GOV

Public Law No: 117-328 (H.R. 2617): Consolidated Appropriations Act, 2023; discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding and National Institutes of Health funding General discussions related to competition, access, and regulatory actions regarding Multi-Cancer Early Detection technology General discussions related to genomic surveillance and pandemic preparedness General discussions related to the Cancer Moonshot Initiative General discussion related to President Biden's Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy

Contacted: HOUSE OF REPRESENTATIVES; Natl Science Foundation (NSF); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Natl Security Council (NSC); Office of Science & Technology Policy (OSTP); U.S. Trade Representative (USTR); SENATE

Bills named: H.R. 2617 (117th)

Trade (domestic/foreign) TRD

H.R. 4521: United States Innovation and Competition Act of 2021; all provisions S. 1260: United States Innovation and Competition Act of 2021; all provisions Public Law No: 117-167 (H.R. 4346): Supreme Court Security Funding Act of 2022 (f.k.a: The CHIPS and Science Act of 2022); all provisions Public Law No: 117-328 (H.R. 2617): Consolidated Appropriations Act, 2023; discussions related to genomics, sequencing, the applications for sequencing including in rare disease and related reimbursement, CDC surveillance funding and National Institutes of Health funding

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2617 (117th), S. 1260 (117th), H.R. 4346 (117th), H.R. 4521 (117th)